Skip to content
healthcare.dev

YUSIMRY

NDC 70114-210, adalimumab-aqvh, injection, solution, from Coherus BioSciences Inc.

Product NDC
70114-210
Status
Listed
Labeler
Coherus BioSciences Inc
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761216
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70114-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB40 mg/.8mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
70114-210-02701140210022 SYRINGE, GLASS in 1 CARTON (70114-210-02) / .8 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cd0e7af2-7704-49ce-bde9-f645294b6788

Use it

Look up 70114-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70114-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70114-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.